PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
16984887-0	2006	Quinocarmycin analog DX-52-1 inhibits cell migration and targets radixin, disrupting interactions of radixin with actin and CD44.	quinocarcin	0-13	radixin	Homo sapiens	65-72
19913059-6	2010	In view of these results, we explored the mode of action of quinocarmycin/quinocarcin analog DX-52-1, an inhibitor of cell migration and radixin function with considerable selectivity for radixin over the other ERM proteins, finding that its mechanism of inhibition of radixin does not appear to involve binding and antagonism at the site of regulatory phosphorylation.	quinocarcin	60-73	radixin	Canis lupus familiaris	137-144
19913059-6	2010	In view of these results, we explored the mode of action of quinocarmycin/quinocarcin analog DX-52-1, an inhibitor of cell migration and radixin function with considerable selectivity for radixin over the other ERM proteins, finding that its mechanism of inhibition of radixin does not appear to involve binding and antagonism at the site of regulatory phosphorylation.	quinocarcin	60-73	radixin	Canis lupus familiaris	188-195
19913059-6	2010	In view of these results, we explored the mode of action of quinocarmycin/quinocarcin analog DX-52-1, an inhibitor of cell migration and radixin function with considerable selectivity for radixin over the other ERM proteins, finding that its mechanism of inhibition of radixin does not appear to involve binding and antagonism at the site of regulatory phosphorylation.	quinocarcin	60-73	radixin	Canis lupus familiaris	188-195
19913059-6	2010	In view of these results, we explored the mode of action of quinocarmycin/quinocarcin analog DX-52-1, an inhibitor of cell migration and radixin function with considerable selectivity for radixin over the other ERM proteins, finding that its mechanism of inhibition of radixin does not appear to involve binding and antagonism at the site of regulatory phosphorylation.	quinocarcin	74-85	radixin	Canis lupus familiaris	137-144
19913059-6	2010	In view of these results, we explored the mode of action of quinocarmycin/quinocarcin analog DX-52-1, an inhibitor of cell migration and radixin function with considerable selectivity for radixin over the other ERM proteins, finding that its mechanism of inhibition of radixin does not appear to involve binding and antagonism at the site of regulatory phosphorylation.	quinocarcin	74-85	radixin	Canis lupus familiaris	188-195
19913059-6	2010	In view of these results, we explored the mode of action of quinocarmycin/quinocarcin analog DX-52-1, an inhibitor of cell migration and radixin function with considerable selectivity for radixin over the other ERM proteins, finding that its mechanism of inhibition of radixin does not appear to involve binding and antagonism at the site of regulatory phosphorylation.	quinocarcin	74-85	radixin	Canis lupus familiaris	188-195
24065889-6	2013	Here, we inhibited radixin function using the quinocarmycin analog DX52-1 which resulted in reduced neuroblast migration in vitro, while glial migration remained unaltered.	quinocarcin	46-59	radixin	Homo sapiens	19-26
21773620-3	2011	Compounds 8 gave anti- and syn-cycloadducts containing the quinocarcin core through a catalyst-free dehydration process.	quinocarcin	59-70	synemin	Homo sapiens	27-30
16984887-0	2006	Quinocarmycin analog DX-52-1 inhibits cell migration and targets radixin, disrupting interactions of radixin with actin and CD44.	quinocarcin	0-13	CD44 molecule (Indian blood group)	Homo sapiens	124-128
16984887-0	2006	Quinocarmycin analog DX-52-1 inhibits cell migration and targets radixin, disrupting interactions of radixin with actin and CD44.	quinocarcin	0-13	radixin	Homo sapiens	101-108
9383416-1	1995	BACKGROUND: Quinocarcin is the simplest of the bioxalmycin/naphthyridinomycin/tetrazomine/saframycin class of anti-tumor antibiotics, which damage DNA in a process that is inhibited by superoxide dismutase (SOD).	quinocarcin	12-23	superoxide dismutase 1	Homo sapiens	185-205
10732968-1	2000	The efficient synthesis of a water-soluble C11a-epi-analogue (6b) of quinocarcin is described.	quinocarcin	69-80	endogenous retrovirus group K member 25	Homo sapiens	43-47
9383416-1	1995	BACKGROUND: Quinocarcin is the simplest of the bioxalmycin/naphthyridinomycin/tetrazomine/saframycin class of anti-tumor antibiotics, which damage DNA in a process that is inhibited by superoxide dismutase (SOD).	quinocarcin	12-23	superoxide dismutase 1	Homo sapiens	207-210